Literature DB >> 3209529

Pharmacokinetics of intravenous ciprofloxacin at three different doses.

B Ljungberg1, I Nilsson-Ehle.   

Abstract

The pharmacokinetics of ciprofloxacin were evaluated after single iv bolus injections of 50, 100 and 250 mg in eight young, healthy male volunteers. Concentrations were determined by high-performance liquid chromatography. The mean terminal half-life was 3.33, 3.73 and 3.45 h for 50, 100 and 250 mg doses, respectively. No significant differences between the three dose levels were noted for terminal half-life, total and renal clearances, distribution volume (Vd(ss] and percentage of dose recovered in urine over 24 h. The areas under the serum concentration curves were proportional to the given dose. We conclude that distribution and elimination of ciprofloxacin is not dose dependent.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3209529     DOI: 10.1093/jac/22.5.715

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Increase of microcirculatory blood flow enhances penetration of ciprofloxacin into soft tissue.

Authors:  Christian Joukhadar; Pejman Dehghanyar; Friederike Traunmüller; Robert Sauermann; Bernhard Mayer-Helm; Apostolos Georgopoulos; Markus Müller
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

2.  Intravenous Push Administration of Antibiotics: Literature and Considerations.

Authors:  Samantha Spencer; Heather Ipema; Patricia Hartke; Courtney Krueger; Ryan Rodriguez; Alan E Gross; Michael Gabay
Journal:  Hosp Pharm       Date:  2018-03-08

Review 3.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

4.  A case study of in silico modelling of ciprofloxacin hydrochloride/metallic compound interactions.

Authors:  Aleksandra Stojkovic; Jelena Parojcic; Zorica Djuric; Owen I Corrigan
Journal:  AAPS PharmSciTech       Date:  2013-12-05       Impact factor: 3.246

Review 5.  A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life.

Authors:  Jan-Frederik Schlender; Donato Teutonico; Katrin Coboeken; Katrin Schnizler; Thomas Eissing; Stefan Willmann; Ulrich Jaehde; Heino Stass
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.